These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 16437480)

  • 1. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
    Hind D; Wyld L; Beverley CB; Reed MW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
    Morgan J; Wyld L; Collins KA; Reed MW
    Cochrane Database Syst Rev; 2014 May; 5(5):CD004272. PubMed ID: 35658165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review.
    Hind D; Wyld L; Reed MW
    Br J Cancer; 2007 Apr; 96(7):1025-9. PubMed ID: 17285133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Goel S; Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.
    Wilcken N; Hornbuckle J; Ghersi D
    Cochrane Database Syst Rev; 2003; 2003(2):CD002747. PubMed ID: 12804433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative tamoxifen for ductal carcinoma in situ.
    Staley H; McCallum I; Bruce J
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007847. PubMed ID: 23076938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (2):CD003374. PubMed ID: 15106201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson L; Lawrence D; Dawson C; Bliss J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003370. PubMed ID: 19821307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Wilcken N; Ghersi D; Marzo M; Simes J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003372. PubMed ID: 15846660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    Jones D; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003368. PubMed ID: 16856005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (3):CD003374. PubMed ID: 15266482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Tamoxifen for early breast cancer.
    Clarke MJ
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD000486. PubMed ID: 18843611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toremifene versus tamoxifen for advanced breast cancer.
    Mao C; Yang ZY; He BF; Liu S; Zhou JH; Luo RC; Chen Q; Tang JL
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008926. PubMed ID: 22786516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.